Product
GEH200520
1 clinical trial
2 indications
Indication
OncologyIndication
Malignant Solid TumorClinical trial
A Phase 1a/1b, Multi-Centre, Open-Label, Dose-Escalation and Dose-Expansion Study in Patients With Solid Tumour Malignancies to Evaluate GEH200520 Injection / GEH200521 (18F) Injection Safety and Tolerability, PET Imaging, Pharmacokinetics, and Changes in Imaging After TreatmentStatus: Recruiting, Estimated PCD: 2024-12-31